Zimbabwe and South Africa have signed a memorandum of understanding (MoU) to strengthen the regulatory frameworks of the two countries in the pharmaceutical sector.
The MoU between the Medicines Control Authority of Zimbabwe (MCAZ) and the South African Health Products Regulatory Authority (SAHPRA) will allow the regulatory bodies to develop a cooperative partnership toward ensuring access to safe, quality and effective health products in the two countries, said MCAZ director-general Richard Rukwata in a statement Friday.
“MCAZ and SAHPRA will cooperate in joint product reviews and inspections to enable efficient access to health products,” Rukwata said. “This partnership will also focus on detection and curbing of substandard and falsified health products moving between the two countries, which has of late been a major challenge that the two regulators have identified.”
The MoU will facilitate cooperation and collaboration between the two neighboring countries in the areas of medicines regulation, quality control and pharmacovigilance, Rukwata added.
